5 Recruiting Locally Advanced Solid Tumor Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for locally advanced solid tumor enrolling across the USA. Verify eligibility and contact site coordinators.
All Locally Advanced Solid Tumor studiesPhase 1 / Phase 2 Studies for Locally Advanced Solid Tumor
🔵 Active, Not Recruiting Phase1 / Phase2
A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
📍 OHSU — Portland, Oregon
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
📍 University of California Irvine Medical Center — Orange, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
📍 Yale Cancer Center-Yale University — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
📍 UCI Medical Center — Orange, California
View Study & Checklist ➔